Revna Biosciences receives historic FDA approval for NeuMoDx™ 96 from QIAGEN, the first in Sub-Saharan Africa
Co-Founder and CEO of Revna Biosciences, Dr Derrick Akpalu
Revna Biosciences receives historic FDA approval for NeuMoDx™ 96 from QIAGEN, the first in Sub-Saharan Africa
Co-Founder and CEO of Revna Biosciences, Dr Derrick Akpalu